cml-cp means chronic phase chronic granulocytic leukemia, which manifests itself in the form of malaise and low-grade fever, and can present with a markedly increased white blood cell count, and can be treated with drugs such as imatinib. cml stands for chronic phase chronic granulocytic leukemia and cp refers to the chronic phase of the disease process. In the chronic phase, systemic symptoms such as malaise, low-grade fever, night sweats, progressive weight loss, and possibly splenomegaly are usually present. Laboratory tests show a small number of white blood cell counts that are significantly higher than 10*10^9 cells/L. In the chronic phase of the disease, a small number of white blood cell counts are found. Treatment of chronic granulocytic leukemia in the chronic phase focuses on individualized therapy in the chronic phase. A series of therapeutic measures can be used, such as targeted drug therapy with imatinib, nilotinib, dasatinib, and chemotherapy with hydroxyurea and cytarabine. The above mentioned drugs such as imatinib, nilotinib, hydroxyurea, cytarabine and so on need to be used under the guidance of clinicians, and unauthorized use of drugs is absolutely prohibited; chronic phase chronic granulocytic leukemia is the key period of treatment, and it is recommended to go to the hospital in time.